Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer (Q36687107)
Jump to navigation
Jump to search
scientific article published on 15 March 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer |
scientific article published on 15 March 2016 |
Statements
1 reference
Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer (English)
1 reference
Shanu Modi
1 reference
Ian E Krop
1 reference
Patricia M LoRusso
1 reference
Mark Pegram
1 reference
Ellie Guardino
1 reference
Betsy Althaus
1 reference
Dan Lu
1 reference
Alexander Strasak
1 reference
Anthony Elias
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference